Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FDA approves pralatrexate for treatment of rare lymphoma.

× No keyword cloud information.

8 in total

Review 1. New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies.

Authors: Kieron Dunleavy; Richard L Piekarz; Jasmine Zain; John E Janik; Wyndham H Wilson; Owen A O'Connor; Susan E Bates
Journal: Clin Cancer Res Date: 2010-12-01 Impact factor: 12.531

Review 2. The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.

Authors: Larry H Matherly; Zhanjun Hou; Aleem Gangjee
Journal: Cancer Chemother Pharmacol Date: 2017-11-10 Impact factor: 3.333

Review 3. The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.

Authors: Larry H Matherly; Mike R Wilson; Zhanjun Hou
Journal: Drug Metab Dispos Date: 2014-01-06 Impact factor: 3.922

4. Discovery of 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as dual-acting inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis: implications of inhibiting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase to ampk activation and antitumor activity.

Authors: Shermaine Mitchell-Ryan; Yiqiang Wang; Larry H Matherly; Aleem Gangjee; Sudhir Raghavan; Manasa Punaha Ravindra; Eric Hales; Steven Orr; Christina Cherian; Zhanjun Hou
Journal: J Med Chem Date: 2013-12-11 Impact factor: 7.446

FDA approves pralatrexate for treatment of rare lymphoma.

Review 1. New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies.

Review 2. The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.

Review 3. The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.

5. Functional and mechanistic roles of the human proton-coupled folate transporter transmembrane domain 6-7 linker.

6. Cancer chemotherapy: targeting folic acid synthesis.

7. How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?

Review 8. The human proton-coupled folate transporter: Biology and therapeutic applications to cancer.